References
- McHaney V A, Thibadoux G, Hayes F A, Gree A A. Hearing loss in children therapy. J Pediatr 1983; 102: 314–7
- Walker D, Pillow J, Waters K, Keir E. Enhanced cis-platinum ototoxicity in children with brain tumors who have received simultaneous or prior cranial irradiation. Med Pediatr Oncol 1989; 17: 48–52
- Laurell G, Jungnelius U. High-dose cisplatin treatment. Hearing loss and plasma concentrations. Laryngoscope 1990; 100: 724–34
- Prestayko A W, D'Aoust J C, Issel B F, Crooke S T. Cisplatin (Cis diamminedichloroplatinum II). Cancer Treat Rev 1979; 6: 17–39
- Laurell G, Andersson A, Engstrom B, Ehrsson H. Distribution of cisplatin in perilymph and cere-brospinal fluid after intravenous administration in the guinea pig. Cancer Chemother Pharmacol 1995; 36: 83–6
- Takeno S, Harrison R V, Mount R, Wake M, Cullen J. Selective inner hair cell damage by carboplatin in the chinchillas: comparison of drug administration routes. XVIIth midwinter research meeting for ARO, St Petersburg, FL, USA, Feb. 6–10, 1994
- Miettinen S, Laurell G, Andersson A, Johansson R, Laurikainen E. Blood flow-independent accumulation of cisplatin in the guinea pig cochlea. Acta Otolaryngol (Stockh) 1997; 117: 55–60
- Löffler J S, Kretschmar C S, Sallan S E, et al. Pre-irradiation chemotherapy for infants and poor prognosis children with medulloblastoma. Int J Radiat Oncol Biol Phys 1988; 15: 177–81
- Kirkbride P, Plowman P N. Platinum chemotherapy, radiotherapy and the inner ear: implications for “standard” irradiation portals. Br J Radiol 1989; 62: 457–62
- Rosental J M, et al. “Eight-drugs-in-one-day” chemotherapy administered before and after radiotherapy to adult patients with malignant gliomas. Cancer 1989; 63: 2475–81
- Schell M J, McHaney V A, Green A A, et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irirradiation. J Clin Oncol 1989; 7: 754–60